{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:16:12Z","timestamp":1724804172908},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.xphs.2024.05.002","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T06:58:34Z","timestamp":1715324314000},"page":"2625-2632","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of Discrimination Models of Cationic Drugs for Phospholipidosis Induction Potential by Using Interaction Data with Immobilized Artificial Membrane as Well as Physicochemical Properties"],"prefix":"10.1016","volume":"113","author":[{"given":"Yoshie","family":"Iwakuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2024.05.002_bib0001","first-page":"327","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"2","author":"Kodavanti","year":"1990","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.xphs.2024.05.002_bib0002","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/17425251003601961","article-title":"Bis(monoacylglycerol)phosphate as a non\u2013invasive biomarker to monitor the onset and time\u2013course of phospholipidosis with drug\u2013induced toxicities","volume":"6","author":"Tengstrand","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6554","key":"10.1016\/j.xphs.2024.05.002_bib0003","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.abi4708","article-title":"Drug\u2013induced phospholipidosis confounds drug repurposing for SARS\u2013CoV\u20132","volume":"373","author":"Tummino","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xphs.2024.05.002_bib0004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.colsurfb.2015.09.003","article-title":"Phospholipidosis effect of drugs by adsorption into lipid monolayers","volume":"136","author":"Ceccarelli","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"10.1016\/j.xphs.2024.05.002_bib0005","first-page":"347","article-title":"Use of physicochemical calculation of pKa and ClogP to predict phospholipidosis\u2013inducing potential: a case study with structurally related piperazines","volume":"55","author":"Ploemen","year":"2004","journal-title":"Exp Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.xphs.2024.05.002_bib0006","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/ci6004542","article-title":"Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential","volume":"47","author":"Pelletier","year":"2007","journal-title":"J Chem Inf Model"},{"issue":"4","key":"10.1016\/j.xphs.2024.05.002_bib0007","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2131\/jts.31.315","article-title":"Physicochemical and cell\u2013based approach for early screening of phospholipidosis\u2013inducing potential","volume":"31","author":"Tomizawa","year":"2006","journal-title":"J Toxicol Sci"},{"issue":"5","key":"10.1016\/j.xphs.2024.05.002_bib0008","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1021\/mp100103e","article-title":"Predicting phospholipidosis using machine learning","volume":"7","author":"Lowe","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.05.002_bib0009","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/minf.201200048","article-title":"Construction and consensus performance of (Q)SAR models for predicting phospholipidosis using a dataset of 743 compounds","volume":"31","author":"Orogo","year":"2012","journal-title":"Mol Inf"},{"issue":"2","key":"10.1016\/j.xphs.2024.05.002_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.taap.2013.03.010","article-title":"In silico modeling to predict drug\u2013induced phospholipidosis","volume":"269","author":"Choi","year":"2013","journal-title":"Toxicol App Pharmacol"},{"issue":"12","key":"10.1016\/j.xphs.2024.05.002_bib0011","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.chembiol.2023.09.003","article-title":"A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis","volume":"30","author":"Hu","year":"2023","journal-title":"Cell Chemical Biol"},{"key":"10.1016\/j.xphs.2024.05.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2022.100226","article-title":"Development of an in silico consensus model for the prediction of the phospholipigenic potential of small molecules","volume":"22","author":"Schieferdecker","year":"2022","journal-title":"Comput Toxicol"},{"issue":"12","key":"10.1016\/j.xphs.2024.05.002_bib0013","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acs.molpharmaceut.7b00388","article-title":"Predicting the risk of phospholipidosis with in silico models and an image-based in vitro screen","volume":"14","author":"Fusani","year":"2017","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2024.05.002_bib0014","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/acs.chemrestox.6b00459","article-title":"Use of the distribution coefficient in brain polar lipids for the assessment of drug\u2013induced phospholipidosis risk","volume":"30","author":"Ceccarelli","year":"2017","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.xphs.2024.05.002_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10337-022-04225-0","article-title":"Immobilized artificial membrane chromatography using acetonitrile\u2013rich mobile phase for comparison of retention properties between phospholipidosis\u2013inducing and non\u2013inducing basic drugs","volume":"86","author":"Iwakuma","year":"2023","journal-title":"Chromatographia"},{"key":"10.1016\/j.xphs.2024.05.002_bib0016","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0021-9673(95)00837-3","article-title":"Immobilized\u2013artificial\u2013membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability","volume":"728","author":"Ong","year":"1996","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.xphs.2024.05.002_bib0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chroma.2008.01.079","article-title":"Electrostatic interactions and ionization effect in immobilized artificial membrane retention: a comparative study with octanol\u2013water partitioning","volume":"1187","author":"Vrakas","year":"2008","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.xphs.2024.05.002_bib0018","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejps.2012.01.008","article-title":"Lipophilic and electrostatic forces encoded in IAM\u2013HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data","volume":"45","author":"Grumetto","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.05.002_bib0019","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1021\/acs.molpharmaceut.6b00397","article-title":"Immobilized artificial membrane HPLC derived parameters vs PAMPA\u2013BBB data in estimating in situ measured blood\u2013brain barrier permeation of drugs","volume":"13","author":"Grumetto","year":"2016","journal-title":"Mol Pharmaceutics"},{"key":"10.1016\/j.xphs.2024.05.002_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijpharm.2016.01.019","article-title":"Polar interactions drug\/phospholipids estimated by IAM\u2013HPLC vs cultured cell line passage data: their relationships and comparison of their effectiveness in predicting drug human intestinal absorption","volume":"500","author":"Grumetto","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2024.05.002_bib0021","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ecoenv.2017.01.028","article-title":"The use of immobilized artificial membrane chromatography to predict bioconcentration of pharmaceutical compounds","volume":"139","author":"Tsopelas","year":"2017","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.xphs.2024.05.002_bib0022","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5599\/admet.5.1.373","article-title":"In vitro membrane binding and protein binding (IAM MB\/PB technology) to estimate in vivo distribution: applications in early drug discovery","volume":"5","author":"Valko","year":"2017","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.xphs.2024.05.002_bib0023","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10337-019-03750-9","article-title":"The limited contribution of the analyte partition to the water\u2013rich layer in immobilized artificial membrane chromatography with an acetonitrile\u2013rich binary mobile phase","volume":"82","author":"Iwakuma","year":"2019","journal-title":"Chromatographia"},{"issue":"3","key":"10.1016\/j.xphs.2024.05.002_bib0024","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1022576400291","article-title":"Prediction of protein structural classes by modified Mahalanobis discriminant algorithm","volume":"17","author":"Liu","year":"1998","journal-title":"J Protein Chem"},{"key":"10.1016\/j.xphs.2024.05.002_bib0025","series-title":"Chapter 7: The Elements of Statistical Learning. Springer Series in Statistics","article-title":"Model assessment and selection","author":"Hastie","year":"2009"},{"issue":"4","key":"10.1016\/j.xphs.2024.05.002_bib0026","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx9003825","article-title":"Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds","volume":"23","author":"Hanumegowda","year":"2010","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"10.1016\/j.xphs.2024.05.002_bib0027","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tiv.2009.09.018","article-title":"Prediction of phospholipidosis\u2013inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis","volume":"24","author":"Kuroda","year":"2010","journal-title":"Toxicol In Vitro"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924001758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924001758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:50:17Z","timestamp":1724741417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924001758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022354924001758"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.05.002","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of Discrimination Models of Cationic Drugs for Phospholipidosis Induction Potential by Using Interaction Data with Immobilized Artificial Membrane as Well as Physicochemical Properties","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}